Cnidium Monnieri Detoxification Formula
Phase 2Small molecule
Cnidium Monnieri Detoxification Formula is one of 15 small molecule programs targeting Papilloma. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
14
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
22 competitors in Papilloma
#DrugCompanyPhaseTrials
1Vistide
GileadApproved
Celebrex
PPhiladelphia Eye Associates
Approved
HPV Vaccine
SShanghai Zerun Biotechnology Co.,Ltd
Phase 3
Taxol
TevaPhase 2
Keytruda
Merck & Co.Phase 2
Recombinant Human GM-CSF
EEastern Cooperative Oncology Group
Phase 3
Gardasil9
Merck & Co.Phase 3
Paraplatin
AAvyxa
Phase 2
Tuoyi
CCoherus Oncology, Inc.
Phase 2
Nonavalent HPV Vaccine
XXiamen University
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- FFudan University